# Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects

> **NCT03424733** · PHASE4 · UNKNOWN · sponsor: **Holy Name Medical Center, Inc.** · enrollment: 50 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Plegridy
- **DRUG:** Prednisone
- **DRUG:** Tylenol Pill

## Key facts

- **NCT ID:** NCT03424733
- **Lead sponsor:** Holy Name Medical Center, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-25
- **Primary completion:** 2020-05-01
- **Final completion:** 2020-05-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2019-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03424733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03424733, "Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03424733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*